Delivered Q1 2026 Total Revenues of $149.4 Million
Results include 28% YoY Increase in Net Product Revenues from FIRDAPSE® & AGAMREE®
Reported Cash and Cash Equivalents of $755.9 Million and No Funded Debt as of March 31, 2026
This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.